Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> COMPANY Latest News

MAY 20, 2013 - Benzinga

A Must Read - Share

UPDATE: Aegis Capital Lowers Pernix Therapeutics PT on Reduced Company Guidance

In a report published Monday, Aegis Capital analyst Raghuram Selvaraju maintained the rating of Buy, and lowered the price target on Pernix Therapeutics (NASDAQ: PTX) to $8.50.

Tags: UPDATE: Aegis Capital Lowers Pernix Therapeutics PT on Reduced Company Guidance,  Company Latest News